Amneal to Participate at Upcoming Investor Conferences
03 November 2023 - 1:00PM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that
Chirag Patel, Co-Chief Executive Officer and President, and Tasos
Konidaris, Chief Financial Officer, will participate in the below
investor conferences.
Jefferies 14th Annual Global Healthcare Conference
November 14, 2023 London, UK Presentation – 8:30 AM GMT
Piper Sandler 35th Annual Healthcare Conference November
28, 2023 New York, New York Presentation – 9:00 AM EST
A live webcast of the presentations will be accessible through
the Investor Relations section of the Company's website at
https://investors.amneal.com. A replay of the webcast will be
posted shortly after the presentation and will be available for 90
days following the event.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is a fully integrated global pharmaceuticals
company. We make healthy possible through the development,
manufacturing, and distribution of a diverse portfolio of
approximately 270 pharmaceutical products, primarily within the
United States. In its Generics segment, the Company is expanding
across a broad range of complex product categories and therapeutic
areas, including injectables and biosimilars. In its Specialty
segment, Amneal has a growing portfolio of branded pharmaceuticals
focused primarily on central nervous system and endocrine
disorders, with a pipeline focused on unmet needs. Through its
AvKARE segment, the Company is a distributor of pharmaceuticals and
other products for the U.S. federal government, retail, and
institutional markets. For more information, please visit
www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231103084537/en/
Investor Anthony DiMeo Head of Investor Relations
anthony.dimeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024